Welcome to Yi Pang, Director, Cancer Clinical Research Strategic Initiatives

-

I am very happy to welcome Yi Pang to the Stanford Cancer Clinical Research Program in the new role of Director, Cancer Clinical Research Strategic Initiatives. She will begin on January 22, 2018. Yi joins from Stanford Health Care where she has held various positions over the last 10 years. Most recently she held administrative director and advisor roles with the International Medical Services (IMS). Prior to joining IMS, Yi held roles of increasing responsibility in the Performance Excellence department. Before joining Stanford Health Care, Yi was Clinical/Marketing Liaison at New York University Langone Medical Center – Hospital for Joint Diseases and an adjunct lecturer in biological sciences at Hunter College.

Yi holds a Master in Healthcare Administration from Cornell University, and Master and Bachelor of Medicine from Shanghai University of Traditional Chinese Medicine. She also holds certificates in Lean and Six Sigma, along with a certificate in Project Management.

This new role of Director, Cancer Clinical Research Strategic Initiatives, will be integral to setting, prioritizing, analyzing, communicating and implementing key strategic initiatives for the Stanford Cancer Clinical Research Program in collaboration with leadership. These initiatives will span many functional areas critical to the conduct of cancer clinical research at Stanford through broad programmatic enhancements or more focused niche efforts that address important processes and procedures. The Director will partner with leaders and stakeholders to support priority, high-impact process developments, evaluations and enhancements.

Yi will be located at 800 Welch Road, 3rd floor. Her contact information will be available soon.

Elizabeth

Welcome to Whitney Greene-Nymo, and Transition of Communications and Outreach Groups

-

Please see the following notice about the creation of a new group that will consolidate communications, outreach and marketing for the institute. The CCTO Communications and Outreach groups will align under this group so starting in the new year, Sarah Pelta and Rachel Mesia will transition to report to Whitney. This is a very exciting opportunity for those groups to be involved with important programs and initiatives at the institute level – this will include clinical research but also other cancer programs that align with the institute’s mission and goals.

—

I am pleased to announce that Whitney Greene-Nymo is joining the Stanford Cancer Institute (SCI) as the new Executive Director of Strategic Communications, Community Outreach and Program Development on Monday, January 8, 2018.

For those who have not had the opportunity to work with Whitney in the past, she joins the SCI leadership team following a nine year tenure at Stanford Health Care (SHC) focused largely on the cancer service line, most recently as the Executive Director of Business Development. Whitney is passionate about all aspects – research, prevention, treatment, education, outreach – of our exciting field of oncology, and her contributions within the Stanford cancer arena are many. On her short list of accomplishments you will find: developing and executing strategies which significantly increased oncology volume and revenue; spearheading SHC’s oncology network development strategy, including the creation of the business plan for Stanford Cancer Center South Bay; and managing the design and construction of the Stanford Women’s Cancer Center. Whitney represents Stanford cancer at a national level as a member of the steering committee of the National Cancer Institute’s Public Affairs and Marketing Network, where she learns and shares best practices with colleagues from NCI-designated cancer centers across the country. Whitney received her MBA from Stanford and her undergraduate degree in mathematics from Duke where she was named to the Phi Beta Kappa honor society.

Our new Executive Director position was created from existing vacancies. Through a central leadership structure, this role will unite and consolidate the current marketing, communications, and community outreach and engagement efforts into one strong and talented team. Goals and objectives will be aligned within the SCI including cancer clinical research, and across the School of Medicine, Stanford Health Care and Lucile Packard Children’s Hospital. Whitney will provide critical strategic oversight for the SCI communications and community outreach efforts with the goal of increasing the SCI’s national and international visibility; positioning the SCI as a leader in basic science, translational and clinical research; and, with her team and in collaboration with others, will execute strategies focused on medically under-served populations in our catchment area. This role joins all of our SCI positions in serving as a steward of valuable SCI resources, and as an ambassador of the SCI both within the SOM, SHC and LPCH, and beyond our local community.

Please join me in welcoming Whitney to the SCI and our leadership team, and in wishing her a long and productive career with the preeminent Stanford Cancer Institute. Whitney can be reached at whgreene@stanford.edu starting in January, and will be reaching out to many of you in her new role and I encourage you to contact her with communication, marketing and community outreach ideas.

We invite you to stop by our suite in the Lokey Building (265 Campus Drive, Suite 2013H) any time to visit in person.

Best,

Laura Adams
SCI Director of Finance and Administration/Associate Director